Is Semaglutide Right for Everyone
Many lupus patients face weight challenges due to corticosteroid therapy, reduced activity, and metabolic complications
A clinical trial with over 2500 people who were either obese or overweight was split into 2 treatment groups: people taking tirzepatide and people in the placebo group
[8] These findings are best understood as angiogenesis-associated model observations, not as evidence of human wound healing efficacy, cardiovascular benefit, or clinical safety
F., Ruschitzka, F., & Muller-Wieland, D
Theyve got access to special care, but its not scalable considering the prevalence of obesity. Given the scope of the obesity epidemic, even the United Kingdoms National Health Service (NHS) is testing digital weight-management technologies to address this unmet need